Resultados da busca - Zhuo, Jianyong

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases por Yang, Xinyu, Lu, Di, Zhuo, Jianyong, Lin, Zuyuan, Yang, Modan, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

The ongoing trends of patient‐derived xenograft models in oncology por Zhuo, Jianyong, Su, Renyi, Tan, Winyen, Lian, Zhengxing, Lu, Di, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

Laparoscopic management of enterohepatic migrated fish bone mimicking liver neoplasm: A case report and literature review por Chen, Jun, Wang, Chao, Zhuo, Jianyong, Wen, Xue, Ling, Qi, Liu, Zhikun, Guo, Haijun, Xu, Xiao, Zheng, Shusen

Obter o texto integral Obter o texto integral Obter o texto integral

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma por Zhang, Xuanyu, Zhuang, Runzhou, Ye, Qianwei, Zhuo, Jianyong, Chen, Kangchen, Lu, Di, Wei, Xuyong, Xie, Haiyang, Xu, Xiao, Zheng, Shusen

Obter o texto integral Obter o texto integral Obter o texto integral

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1 por Ling, Sunbin, Xie, Haiyang, Yang, Fan, Shan, Qiaonan, Dai, Haojiang, Zhuo, Jianyong, Wei, Xuyong, Song, Penghong, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Obter o texto integral Obter o texto integral Obter o texto integral

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma por Wang, Jianguo, Zhuo, Jianyong, Tao, Yaoye, Xu, Shengjun, Chen, Zun, Yang, Fan, Ke, Qinghong, Xie, Haiyang, Zheng, Shusen, Wang, Hangxiang, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts por Zhuo, Jianyong, Lu, Di, Wang, Jianguo, Lian, Zhengxing, Zhang, Jiali, Li, Huihui, Cen, Beini, Wei, Xuyong, Wei, Qiang, Xie, Haiyang, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma por Zhuang, Runzhou, Lu, Di, Zhuo, Jianyong, Zhang, Xuanyu, Wang, Kun, Wei, Xuyong, Wei, Qiang, Wang, Wei, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Obter o texto integral Obter o texto integral Obter o texto integral

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma por Lu, Di, Yang, Fan, Zhuo, Jianyong, Yang, Modan, Lin, Zuyuan, Jin, Pingbo, Cai, Xuechun, Cen, Beini, Wang, Jianguo, Wei, Xuyong, Zheng, Shusen, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study por Shen, Xiaoyong, Yang, Fan, Yang, Pengfei, Yang, Modan, Xu, Lei, Zhuo, Jianyong, Wang, Jianguo, Lu, Di, Liu, Zhikun, Zheng, Shu-sen, Niu, Tianye, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation por Yang, Xinyu, Lu, Di, Wang, Rui, Lian, Zhengxing, Lin, Zuyuan, Zhuo, Jianyong, Chen, Hao, Yang, Modan, Tan, Winyen, Yang, Mengfan, Wei, Xuyong, Wei, Qiang, Zheng, Shusen, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy por Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral

Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021) por Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Obter o texto integral Obter o texto integral

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib por Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao

Obter o texto integral Obter o texto integral Obter o texto integral